Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
TWST — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

23.36

Margin Of Safety %

Put/Call OI Ratio

0.8

EPS Next Q Diff

0.38

EPS Last/This Y

-0.69

EPS This/Next Y

-0.06

Price

60.55

Target Price

68

Analyst Recom

1.22

Performance Q

25.95

Upside

-176.9%

Beta

2.21

Ticker: TWST




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23TWST58.760.211.243727
2026-04-24TWST60.970.230.223791
2026-04-27TWST61.060.230.053810
2026-04-28TWST59.120.230.003907
2026-04-29TWST56.720.2947.004106
2026-04-30TWST58.360.390.054434
2026-05-01TWST60.40.390.874504
2026-05-04TWST56.180.402.394640
2026-05-05TWST56.690.611.285672
2026-05-06TWST59.530.670.326118
2026-05-07TWST58.570.670.366155
2026-05-08TWST56.850.670.026171
2026-05-11TWST56.220.660.096190
2026-05-12TWST55.940.650.106253
2026-05-13TWST54.40.660.186262
2026-05-14TWST52.970.660.126262
2026-05-15TWST49.180.700.816482
2026-05-18TWST49.751.100.363817
2026-05-19TWST49.561.030.074080
2026-05-20TWST53.711.020.084094
2026-05-21TWST58.90.820.274675
2026-05-22TWST60.580.800.064857
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23TWST58.8019.7- -1.97
2026-04-24TWST60.9519.7- -1.97
2026-04-27TWST61.0619.7- -1.97
2026-04-28TWST59.2019.7- -1.97
2026-04-30TWST58.3619.7- -1.97
2026-05-01TWST60.3619.7- -1.97
2026-05-04TWST56.1219.7- -1.97
2026-05-05TWST56.6419.7- -1.97
2026-05-06TWST59.5319.7- -1.97
2026-05-07TWST58.57-5.0- -1.97
2026-05-08TWST56.79- - -1.99
2026-05-11TWST56.18- - -1.99
2026-05-12TWST55.90- - -1.99
2026-05-13TWST54.40- - -1.99
2026-05-14TWST52.99- - -1.99
2026-05-15TWST49.18- - -1.99
2026-05-18TWST49.80- - -1.99
2026-05-19TWST49.53- - -1.99
2026-05-20TWST53.69- - -1.99
2026-05-21TWST58.84- - -1.99
2026-05-22TWST60.55- - -1.99
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23TWST-10.952.5624.13
2026-04-24TWST-11.082.5624.13
2026-04-27TWST-11.082.5724.77
2026-04-28TWST-11.112.5724.77
2026-04-29TWST-11.122.5724.77
2026-04-30TWST-11.122.5724.77
2026-05-01TWST-11.122.5724.77
2026-05-04TWST-9.042.1924.77
2026-05-05TWST-9.042.1924.77
2026-05-06TWST-8.732.1924.77
2026-05-07TWST-8.952.1924.39
2026-05-08TWST-8.952.1924.39
2026-05-11TWST-8.95-0.3824.38
2026-05-12TWST-8.99-0.3823.36
2026-05-13TWST-9.14-0.3823.36
2026-05-14TWST-9.14-0.3823.36
2026-05-15TWST-9.51-0.3823.36
2026-05-18TWST-9.51-4.7323.36
2026-05-19TWST-9.53-4.7323.36
2026-05-20TWST-9.53-4.7323.36
2026-05-21TWST-9.31-4.7323.36
2026-05-22TWST-9.31-4.7323.36
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.71

Avg. EPS Est. Current Quarter

-0.43

Avg. EPS Est. Next Quarter

-0.33

Insider Transactions

-9.31

Institutional Transactions

-4.73

Beta

2.21

Average Sales Estimate Current Quarter

114

Average Sales Estimate Next Quarter

117

Fair Value

Quality Score

37

Growth Score

44

Sentiment Score

79

Actual DrawDown %

56.8

Max Drawdown 5-Year %

-91.5

Target Price

68

P/E

Forward P/E

PEG

P/S

9.21

P/B

8.27

P/Free Cash Flow

EPS

-1.33

Average EPS Est. Cur. Y​

-1.99

EPS Next Y. (Est.)

-2.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-19.85

Relative Volume

1.29

Return on Equity vs Sector %

-44.9

Return on Equity vs Industry %

-28.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.33

EBIT Estimation

TWST Healthcare
$60.57
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
4/25
Volume
1/15
Valuation
6/20
TP/AR
6/10
Options
4/10
RSI
60.1
Range 1M
81.7%
Sup Dist
10.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
41 /100
WEAK
Momentum
10/25
Growth
13/30
Estimates
5/20
Inst/Vol
6/15
Options
7/10
EPS Yr
-58%
EPS NY
33.1%
52W%
86.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +12.3% upside
Quality
5/30
Valuation
5/30
Growth
10/25
Stability
8/10
LT Trend
3/5
Upside
+12.3%
Quality
37
Twist Bioscience Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 979
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
TWST

Latest News

Caricamento notizie per TWST
stock quote shares TWST – Twist Bioscience Corporation Stock Price stock today
news today TWST – Twist Bioscience Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TWST – Twist Bioscience Corporation yahoo finance google finance
stock history TWST – Twist Bioscience Corporation invest stock market
stock prices TWST premarket after hours
ticker TWST fair value insiders trading